Cargando…
Impact of DPP-4 inhibitors on plasma levels of BNP and NT-pro-BNP in type 2 diabetes mellitus
BACKGROUND: Dipeptidyl peptidase-4 inhibitors (DPP-4i) decrease glucose levels by regulating incretin peptides in type 2 diabetes mellitus (T2DM). This study aimed to determine the modulatory effect of DPP-4i on brain natriuretic peptide (BNP) and N-terminal pro-brain natriuretic peptide (NT-pro-BNP...
Autores principales: | Mu, Liying, Wang, Zhuo, Ren, Jinmei, Xiong, Xiaowei, Jin, Zening, Liu, Xin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8842815/ https://www.ncbi.nlm.nih.gov/pubmed/35164839 http://dx.doi.org/10.1186/s13098-022-00797-x |
Ejemplares similares
-
Die Biomarker BNP und NT‑proBNP
por: Oremek, G. M., et al.
Publicado: (2023) -
Agreement of BNP and NT-proBNP and the influence of clinical and laboratory variables
por: Curiati, Milena Novaes Cardoso, et al.
Publicado: (2013) -
The association of plasma NT-proBNP level and progression of diabetic kidney disease
por: Zhao, Yuancheng, et al.
Publicado: (2023) -
Serum Levels of NT-Pro BNP in Patients with Preeclampsia
por: Nguyen, Thanh Xuan, et al.
Publicado: (2022) -
Natriuretic peptides (BNP and NT-proBNP): measurement and relevance in heart failure
por: Palazzuoli, A, et al.
Publicado: (2010)